{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:23:12Z","timestamp":1788276192450,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","award":["SLJ0209"],"award-info":[{"award-number":["SLJ0209"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.therap.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T20:34:50Z","timestamp":1618950890000},"page":"617-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy"],"prefix":"10.1016","volume":"76","author":[{"given":"Ke","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2021.04.002_bib0300","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2021.04.002_bib0305","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear?","volume":"7","author":"Gentile","year":"2016","journal-title":"Diabetes Therapy"},{"issue":"4 Pt 2","key":"10.1016\/j.therap.2021.04.002_bib0310","first-page":"4S7","article-title":"Subcutaneous insulin: pharmacokinetic variability and glycemic variability","volume":"31","author":"Guerci","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.therap.2021.04.002_bib0315","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1753-0407.2010.00077.x","article-title":"Results and analysis of the 2008-2009 insulin injection technique questionnaire survey","volume":"2","author":"De Coninck","year":"2010","journal-title":"J Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-018-0561-7","article-title":"Impact of insulin injection and infusion routines on lipohypertrophy and glycemic control in children and adults with diabetes","volume":"10","author":"Deeb","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.therap.2021.04.002_bib0325","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1756-0500-4-290","article-title":"Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors","volume":"4","author":"Omar","year":"2011","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.therap.2021.04.002_bib0330","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s13410-019-00735-0","article-title":"Exploring the factors associated with lipohypertrophy in insulin-treated type 2 diabetes patients in a tertiary care hospital in Mumbai, India","volume":"39","author":"Pahuja","year":"2019","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/j.therap.2021.04.002_bib0335","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","article-title":"Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes","volume":"39","author":"Blanco","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.therap.2021.04.002_bib0340","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0145721716648017","article-title":"Improvement of insulin injection technique: examination of current issues and recommendations","volume":"42","author":"Spollett","year":"2016","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.therap.2021.04.002_bib0345","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc16-0610","article-title":"Insulin injection into lipohypertrophic tissue: Blunted and more variable insulin absorption and action and impaired postprandial glucose control","volume":"39","author":"Famulla","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2021.04.002_bib0350","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.mayocp.2016.06.010","article-title":"New insulin delivery recommendations","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.therap.2021.04.002_bib0355","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdi.12742","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetes patients: A systematic review and meta-analysis","volume":"9","author":"Deng","year":"2018","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.therap.2021.04.002_bib0360","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s13300-020-00876-0","article-title":"Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in southern Italy","volume":"11","author":"Gentile","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.therap.2021.04.002_bib0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.therap.2021.04.002_bib0370","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2021.04.002_bib0375","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data","volume":"9","author":"Wallace","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.therap.2021.04.002_bib0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"Supplement 1","key":"10.1016\/j.therap.2021.04.002_bib0385","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/db20-674-P","article-title":"Missed diagnosis of lipohypertrophy by inspection and palpation: prevalence and contributing risk factors","volume":"69","author":"Xu","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0390","first-page":"224","article-title":"The prevalence of lipohypertrophy and its associated factors among Saudi patients with type 2 diabetes mellitus","volume":"15","author":"AlJaber","year":"2020","journal-title":"J Taibah Univ Med Sci"},{"issue":"Supplement 1","key":"10.1016\/j.therap.2021.04.002_bib0395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2337\/db19-59-LB","article-title":"Prevalence and risk factors of lipohypertrophy and lipoatrophy in diabetes patients receiving insulin therapy","volume":"68","author":"Buyruk Ba","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4910962","article-title":"Effect of insulin-induced lipodystrophy on glycemic control among children and adolescents with diabetes in Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia","volume":"2018","author":"Tsadik","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.therap.2021.04.002_bib0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15171\/jcs.2018.011","article-title":"Lipohypertrophy in individuals with type 2 diabetes: prevalence and risk factors","volume":"7","author":"Arda S\u00fcr\u00fcc\u00fc","year":"2018","journal-title":"J Caring Sci"},{"key":"10.1016\/j.therap.2021.04.002_bib0410","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fendo.2018.00638","article-title":"Insulin-related lipohypertrophy: lipogenic action or tissue trauma?","volume":"9","author":"Barola","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.therap.2021.04.002_bib0415","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/dme.13764","article-title":"Ultrasound detection of insulin-induced lipohypertrophy in type 1 and type 2 diabetes","volume":"35","author":"Kapeluto","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.therap.2021.04.002_bib0420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/dia.2018.0074","article-title":"Clinical implications of lipohypertrophy among people with type 1 diabetes in India","volume":"20","author":"Gupta","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.therap.2021.04.002_bib0425","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00592-017-1066-y","article-title":"Errors in insulin treatment management and risk of lipohypertrophy","volume":"55","author":"Pozzuoli","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.therap.2021.04.002_bib0430","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s13300-017-0315-y","article-title":"A Randomized controlled trial to assess the impact of proper insulin injection technique training on glycemic control","volume":"8","author":"Misnikova","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.therap.2021.04.002_bib0435","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/dia.2016.0334","article-title":"Lipohypertrophy in China: Prevalence, risk factors, insulin consumption, and clinical impact","volume":"19","author":"Ji","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.therap.2021.04.002_bib0440","first-page":"00257","article-title":"Dermatological manifestations among diabetic children (0-16) years in Jaber Abo Eliz Diabetic Center, Albulk Children Hospital, in Khartoum, Sudan (March, 2011-March, 2012)","volume":"6","author":"Hussein","year":"2017","journal-title":"J Pediatr Neonatal Care"},{"key":"10.1016\/j.therap.2021.04.002_bib0445","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1111\/jocn.13801","article-title":"Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy","volume":"26","author":"Hernar","year":"2017","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.therap.2021.04.002_bib0450","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/ijem.IJEM_548_16","article-title":"An audit of insulin usage and insulin injection practices in a large Indian cohort","volume":"21","author":"Baruah","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.therap.2021.04.002_bib0455","first-page":"44","article-title":"Cutaneous manifestations among Egyptian children and adolescents with type 1 diabetes","volume":"64","author":"Youssef","year":"2016","journal-title":"Egypt Pediatr Assoc Gaz"},{"key":"10.1016\/j.therap.2021.04.002_bib0460","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17140\/DROJ-2-126","article-title":"Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign","volume":"2","author":"Strollo","year":"2016","journal-title":"Diabetes Res Open J"},{"key":"10.1016\/j.therap.2021.04.002_bib0465","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.dsx.2016.09.010","article-title":"Assessment of insulin injection techniques among diabetes patients in a tertiary care centre","volume":"11","author":"Patil","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.therap.2021.04.002_bib0470","first-page":"13178","article-title":"Injection sites lipohypertrophy among 736 patients with type 2 diabetes of different-grade hospitals","volume":"9","author":"Li","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.therap.2021.04.002_bib0475","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.mayocp.2016.06.012","article-title":"Worldwide injection technique questionnaire study: injecting complications and the role of the professional","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.therap.2021.04.002_bib0480","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-016-0161-3","article-title":"Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: a cross-sectional study","volume":"7","author":"Al Hayek","year":"2016","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.therap.2021.04.002_bib0485","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0034-1394381","article-title":"Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes","volume":"123","author":"Binder","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0490","doi-asserted-by":"crossref","first-page":"e20776","DOI":"10.5812\/ijem.20776","article-title":"Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus","volume":"13","author":"Al Ajlouni","year":"2015","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.therap.2021.04.002_bib0495","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/bjd.13077","article-title":"Spectrum of cutaneous manifestations of type 1 diabetes mellitus in 500 south Asian patients","volume":"171","author":"Sawatkar","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.therap.2021.04.002_bib0500","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/edn.255","article-title":"Dermatological complications of insulin therapy in children with type 1 diabetes","volume":"11","author":"van Munster","year":"2014","journal-title":"Eur Diabetes Nurs"},{"key":"10.1016\/j.therap.2021.04.002_bib0505","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1185\/03007995.2014.895711","article-title":"Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010","volume":"30","author":"Ji","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.therap.2021.04.002_bib0510","first-page":"145","article-title":"Optimizing insulin injection technique and its effect on blood glucose control","volume":"1","author":"Grassi","year":"2014","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.therap.2021.04.002_bib0515","first-page":"340","article-title":"Lipohypertrophy in insulin-treated diabetes: Prevalence and associated risk factors","volume":"17","author":"Cunningham","year":"2013","journal-title":"J Diabetes Nurs"},{"key":"10.1016\/j.therap.2021.04.002_bib0520","first-page":"1196","article-title":"Frequency of lipodystrophy induced by recombinant human insulin","volume":"15","author":"Hajheydari","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.therap.2021.04.002_bib0525","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-5448.2008.00477.x","article-title":"Dermatological side effects and complications of continuous subcutaneous insulin infusion in preschool-age and school-age children","volume":"10","author":"Schober","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0530","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpeds.2007.10.006","article-title":"Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents","volume":"152","author":"Conwell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.therap.2021.04.002_bib0535","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2006.12.023","article-title":"Incidence of lipohypertrophy in diabetic patients and a study of influencing factors","volume":"77","author":"Vardar","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.therap.2021.04.002_bib0540","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc07-0267","article-title":"The prevalence of cutaneous manifestations in young patients with type 1 diabetes","volume":"30","author":"Pavlovi\u0107","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2021.04.002_bib0545","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pdi.314","article-title":"A pan-European epidemiologic study of insulin injection technique in patients with diabetes","volume":"19","author":"Strauss","year":"2002","journal-title":"Pract Diabetes Int"},{"key":"10.1016\/j.therap.2021.04.002_bib0550","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diacare.25.3.634","article-title":"Lipohypertrophy in young patients with type 1 diabetes","volume":"25","author":"Kordonouri","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.therap.2021.04.002_bib0555","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-2001-18991","article-title":"Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes","volume":"109","author":"Raile","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0560","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pdi.91","article-title":"Insulin injection practices","volume":"17","author":"Partanen","year":"2000","journal-title":"Pract Diabetes Int"},{"key":"10.1016\/j.therap.2021.04.002_bib0565","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pdi.1960150108","article-title":"Factors related to lipohypertrophy in insulin-treated diabetic patients: role of educational intervention","volume":"15","author":"Ibarra","year":"1998","journal-title":"Pract Diabetes Int"},{"key":"10.1016\/j.therap.2021.04.002_bib0570","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/004947559602600406","article-title":"Systematic inspection of insulin injection sites for local complications related to incorrect injection technique","volume":"26","author":"Seyoum","year":"1996","journal-title":"Trop Doct"},{"key":"10.1016\/j.therap.2021.04.002_bib0575","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/pgmj.64.757.850","article-title":"Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins","volume":"64","author":"McNally","year":"1988","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.therap.2021.04.002_bib0580","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0029-1211431","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors","volume":"104","author":"Hauner","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.therap.2021.04.002_bib0585","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/DMSO.S227664","article-title":"Glycemic control, diabetes complications and their determinants among ambulatory diabetes mellitus patients in southwest ethiopia: A prospective cross-sectional study","volume":"13","author":"YimamAhmed","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.therap.2021.04.002_bib0590","first-page":"S5","article-title":"Burden of illness in type 2 diabetes mellitus","volume":"24","author":"Cannon","year":"2018","journal-title":"J Manag Care Spec Pharm"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:47Z","timestamp":1758567347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595721000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0040595721000986"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2021.04.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}